查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1523173

腸外營養市場報告：2030 年趨勢、預測與競爭分析

Parenteral Nutrition Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腸外營養趨勢與預測

預計到 2030 年，全球腸外營養市場預計將達到 73 億美元，2024 年至 2030 年複合年成長率為 6.4%。該市場的主要驅動力是營養不良和慢性病的增加、消費者對臨床營養意識的提高以及對單劑量腸外營養產品的日益偏好。全球腸外營養市場的未來前景廣闊，碳水化合物、腸外脂肪乳劑、單劑量胺基酸溶液、微量元素以及維生素和礦物質市場充滿機會。

腸外營養：按細分市場

研究包括按階段類型、適應症、營養類型和地區對全球腸外營養的預測。

腸外營養市場洞察

Lucintel 預計，在預測期內，成人使用仍將佔據很大一部分。

在該市場中，在預測期內，單劑量胺基酸溶液將繼續成為最大的細分市場。

在預測期內，北美仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球腸外營養市場預計將達到 73 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球腸外營養市場預估複合年增率為6.4%。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是營養不良和慢性病的增加、消費者對臨床營養意識的增強以及對單劑量腸外營養產品的日益偏好。

Q4.市場的主要細分市場是：

A4.腸外營養市場的前景廣闊，碳水化合物、腸外脂肪乳、單劑量胺基酸溶液、微量元素、維生素和礦物質市場都有機會。

Q5.市場的主要企業是：

A5. 主要腸外營養公司如下：

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計成人使用在預測期內仍將佔據較大佔有率。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 在預測期內，北美仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球腸外營養市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球腸外營養市場趨勢（2018-2023）與預測（2024-2030）
  • 按階段類型分類的全球腸外營養市場
    • 成人
    • 兒科的
  • 按適應症分類的全球腸外營養市場
    • 阿茲海默症
    • 營養不良
    • 癌症治療
    • 糖尿病
    • 慢性腎臟病
    • 罕見疾病
    • 吞嚥困難
    • 其他
  • 按營養類型分類的全球腸外營養市場
    • 碳水化合物
    • 腸外脂肪乳劑
    • 單劑量氨基酸溶液
    • 微量元素
    • 維生素和礦物質

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球腸外營養市場區域分佈
  • 北美腸外營養市場
  • 歐洲腸外營養市場
  • 亞太腸外營養市場
  • 其他地區腸外營養市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球腸外營養市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球腸外營養市場的能力
    • 全球腸外營養市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer
簡介目錄

Parenteral Nutrition Trends and Forecast

The future of the global parenteral nutrition market looks promising with opportunities in the carbohydrate, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamin & mineral markets. The global parenteral nutrition market is expected to reach an estimated $7.3 billion by 2030 with a CAGR of 6.4% from 2024 to 2030. The major drivers for this market are rising cases of malnutrition and chronic diseases, increasing awareness about clinical nutrition among consumers, and growing preference for single-dose parenteral nutrition products.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Parenteral Nutrition by Segment

The study includes a forecast for the global parenteral nutrition by stage type, indication, nutrient type, and region.

Parenteral Nutrition Market by Stage Type [Shipment Analysis by Value from 2018 to 2030]:

  • Adult
  • Pediatrics

Parenteral Nutrition Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Others

Parenteral Nutrition Market by Nutrient Type [Shipment Analysis by Value from 2018 to 2030]:

  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals

Parenteral Nutrition Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Parenteral Nutrition Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies parenteral nutrition companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the parenteral nutrition companies profiled in this report include-

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer

Parenteral Nutrition Market Insights

Lucintel forecasts that adult will remain larger segment over the forecast period.

Within this market, single dose amino acid solution will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Parenteral Nutrition Market

Market Size Estimates: Parenteral nutrition market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Parenteral nutrition market size by stage type, indication, nutrient type, and region in terms of value ($B).

Regional Analysis: Parenteral nutrition market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different stage types, indications, nutrient types, and regions for the parenteral nutrition market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the parenteral nutrition market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the parenteral nutrition market size?

Answer: The global parenteral nutrition market is expected to reach an estimated $7.3 billion by 2030.

Q2. What is the growth forecast for parenteral nutrition market?

Answer: The global parenteral nutrition market is expected to grow with a CAGR of 6.4% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the parenteral nutrition market?

Answer: The major drivers for this market are rising cases of malnutrition and chronic diseases, increasing awareness about clinical nutrition among consumers, and growing preference for single-dose parenteral nutrition products.

Q4. What are the major segments for parenteral nutrition market?

Answer: The future of the parenteral nutrition market looks promising with opportunities in the carbohydrate, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamin & mineral markets.

Q5. Who are the key parenteral nutrition market companies?

Answer: Some of the key parenteral nutrition companies are as follows:

  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory
  • Actavis
  • B. Braun Melsungen
  • Fresenius Kabi
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical
  • Pfizer

Q6. Which parenteral nutrition market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain larger segment over the forecast period.

Q7. In parenteral nutrition market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the parenteral nutrition market by stage type (adult and pediatrics), indication (Alzheimer's, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, and others), nutrient type (carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Parenteral Nutrition Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Parenteral Nutrition Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Parenteral Nutrition Market by Stage Type
    • 3.3.1: Adult
    • 3.3.2: Pediatrics
  • 3.4: Global Parenteral Nutrition Market by Indication
    • 3.4.1: Alzheimer's
    • 3.4.2: Nutrition Deficiency
    • 3.4.3: Cancer Care
    • 3.4.4: Diabetes
    • 3.4.5: Chronic Kidney Diseases
    • 3.4.6: Orphan Diseases
    • 3.4.7: Dysphagia
    • 3.4.8: Others
  • 3.5: Global Parenteral Nutrition Market by Nutrient Type
    • 3.5.1: Carbohydrates
    • 3.5.2: Parenteral Lipid Emulsion
    • 3.5.3: Single Dose Amino Acid Solution
    • 3.5.4: Trace Elements
    • 3.5.5: Vitamins & Minerals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Parenteral Nutrition Market by Region
  • 4.2: North American Parenteral Nutrition Market
    • 4.2.1: North American Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.2.2: North American Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals
  • 4.3: European Parenteral Nutrition Market
    • 4.3.1: European Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.3.2: European Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals
  • 4.4: APAC Parenteral Nutrition Market
    • 4.4.1: APAC Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.4.2: APAC Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals
  • 4.5: ROW Parenteral Nutrition Market
    • 4.5.1: ROW Parenteral Nutrition Market by Stage Type: Adult and Pediatrics
    • 4.5.2: ROW Parenteral Nutrition Market by Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Parenteral Nutrition Market by Stage Type
    • 6.1.2: Growth Opportunities for the Global Parenteral Nutrition Market by Indication
    • 6.1.3: Growth Opportunities for the Global Parenteral Nutrition Market by Nutrient Type
    • 6.1.4: Growth Opportunities for the Global Parenteral Nutrition Market by Region
  • 6.2: Emerging Trends in the Global Parenteral Nutrition Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Parenteral Nutrition Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Parenteral Nutrition Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter
  • 7.2: Grifols
  • 7.3: Allergan
  • 7.4: Otsuka Pharmaceutical Factory
  • 7.5: Actavis
  • 7.6: B. Braun Melsungen
  • 7.7: Fresenius Kabi
  • 7.8: Vifor Pharma
  • 7.9: Sichuan Kelun Pharmaceutical
  • 7.10: Pfizer